Patent · US Active

Drug delivery device with activation prevention feature

US11590277B2 · kind B2 · utility

4Cited by

12References

10Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Brian Stonecipher · Newbury Park, US
Margaux Frances Boyaval · Newbury Park, US
James Chan · San Marino, US
Avon Kuo · San Jose, US
Allan Cameron · Natick, US
Maxwell Franklin Bischoff · Somerville, US
Gregg Allen Flender · Bedford, US

Key dates

Filing date	Mar 6, 2018
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Mar 16, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2207/00
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A wearable drug delivery device includes an injector having a housing, a reservoir, a needle or cannula, a drive mechanism for urging drug product out of the reservoir, through the needle or cannula, and to a patient, and an activator mechanism disposed on a surface of the housing for activating the drive mechanism. An activation prevention mechanism is coupled to the injector housing and/or activation prevention mechanism to prevent inadvertent actuation of the activator mechanism.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.